Etrasimod, Pfizer’s oral S1P receptor modulator, has won approval from the US Food and Drug Administration (FDA) to treat adults with moderately to severely act 13 October 2023
Wednesday was a good day for the Supernus Pharmaceuticals subsidiary US WorldMeds as the US Food and Drug Administration (FDA) moved a step closer to a potentia 5 October 2023
The US Food and Drug Administration has updated the emergency use authorization for the COVID-19 vaccine developed by US biotech Novavax. 4 October 2023
Privately-held Swiss dermatology company Galderma has announced some bad news relating to its pending Biologics License Application (BLA) for relabotulinumtoxin 3 October 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.